These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 4959376)

  • 21. [Studies on the antituberculous activity of 4, 4'-diisoamyloxythiocarvanilide in vitro].
    Maekawa N; Tsukuma S; Kamada M; Iawi K; Saiga S
    Bull Chest Dis Res Inst Kyoto Univ; 1968 Sep; 2(1):147-54 passim. PubMed ID: 4979433
    [No Abstract]   [Full Text] [Related]  

  • 22. Chemoresistance to Isoxyl. Its determination and its evaluation.
    Muzikravić T
    Antibiot Chemother; 1970; 16():177-81. PubMed ID: 4108884
    [No Abstract]   [Full Text] [Related]  

  • 23. [Emergent strains of rifampicin-resistant Mycobacterium tuberculosis complex and susceptibility to isoniazid].
    Cacho-Calvo J; Martín-Díaz A;
    Enferm Infecc Microbiol Clin; 2013; 31(7):486-7. PubMed ID: 23623580
    [No Abstract]   [Full Text] [Related]  

  • 24. [Research on the antituberculous activity of some derivatives with thioamide or thionester function].
    Reynaud P; Cohen VI; Moreau RC; Rist N; Grumbach F
    Ann Pharm Fr; 1966 Dec; 24(12):769-80. PubMed ID: 4965595
    [No Abstract]   [Full Text] [Related]  

  • 25. Genotypic and phenotypic resistance of Mycobacterium tuberculosis to rifamycins and fluoroquinolones.
    Yew WW; Chan E; Chan CY; Cheng AF
    Int J Tuberc Lung Dis; 2002 Oct; 6(10):936-7. PubMed ID: 12365583
    [No Abstract]   [Full Text] [Related]  

  • 26. Clinical evaluation of the microscopic observation drug susceptibility assay for detection of Mycobacterium tuberculosis resistance to isoniazid or rifampin.
    Mello FC; Arias MS; Rosales S; Marsico AG; Pavón A; Alvarado-Gálvez C; Pessôa CL; Pérez M; Andrade MK; Kritski AL; Fonseca LS; Chaisson RE; Kimerling ME; Dorman SE
    J Clin Microbiol; 2007 Oct; 45(10):3387-9. PubMed ID: 17699652
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Bactericidal therapy in patients with tuberculosis].
    Krasnov VA; Ursov IG
    Probl Tuberk Bolezn Legk; 2004; (3):21-6. PubMed ID: 15338895
    [No Abstract]   [Full Text] [Related]  

  • 28. [In vitro activities of rifabutine and rifampicin against various mycobacteria, especially Mycobacterium tuberculosis and Mycobacterium avium complex].
    Saito H; Sato K; Tomioka H
    Kekkaku; 1988 Mar; 63(3):167-72. PubMed ID: 2836649
    [No Abstract]   [Full Text] [Related]  

  • 29. Significance of intracellular medium for antimycobacterial activity of some pyrazin-2-carbonic acid derivatives.
    Soloviev VN; Pavlov EP
    Chemotherapy; 1966; 11(6):345-54. PubMed ID: 4961407
    [No Abstract]   [Full Text] [Related]  

  • 30. [Studies on the activity of the new antitubercular drugs: Pyrazinamide, rifomycin, 11.072 R. P].
    Manowska W
    Gruzlica; 1968 Apr; 36(4):387-8. PubMed ID: 4971135
    [No Abstract]   [Full Text] [Related]  

  • 31. Evaluation of GenoFlow DR-MTB Array Test for Detection of Rifampin and Isoniazid Resistance in Mycobacterium tuberculosis.
    Molina-Moya B; Kazdaglis G; Lacoma A; Prat C; Gómez A; Villar-Hernández R; García-García E; Haba L; Maldonado J; Samper S; Ruiz-Manzano J; Domínguez J
    J Clin Microbiol; 2016 Apr; 54(4):1160-3. PubMed ID: 26865688
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metronidazole plus rifampin sterilizes long-term dormant Mycobacterium tuberculosis.
    Iona E; Giannoni F; Pardini M; Brunori L; Orefici G; Fattorini L
    Antimicrob Agents Chemother; 2007 Apr; 51(4):1537-40. PubMed ID: 17242153
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Phage amplified biologically assay and its application in rapid detection of Mycobacterium tuberculosis].
    Hu ZY
    Zhonghua Jie He He Hu Xi Za Zhi; 2004 Dec; 27(12):850-2. PubMed ID: 15730788
    [No Abstract]   [Full Text] [Related]  

  • 34. [Antitubercular properties of some derivatives of pyrazine carboxylic acid].
    Solov'ev VN; Pavolo EP
    Farmakol Toksikol; 1967; 30(6):734-7. PubMed ID: 4970686
    [No Abstract]   [Full Text] [Related]  

  • 35. Drug resistance in tuberculosis.
    Ebrahim GJ
    J Trop Pediatr; 2007 Jun; 53(3):147-9. PubMed ID: 17526511
    [No Abstract]   [Full Text] [Related]  

  • 36. Rapid genotypic detection of rifampin- and isoniazid-resistant Mycobacterium tuberculosis directly in clinical specimens.
    Bang D; Bengård Andersen A; Thomsen VØ
    J Clin Microbiol; 2006 Jul; 44(7):2605-8. PubMed ID: 16825393
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [State of resistance to rifampicin and other minor antibiotics and bacteriostatic agents in Turkey].
    Gürsel A; Gürdağ G; Atay N; Biçen E
    Turk Hij Tecr Biyol Derg (1961); 1971; 31(2):136-52. PubMed ID: 5004500
    [No Abstract]   [Full Text] [Related]  

  • 38. [Treatment with new antitubercular agents].
    Gartmann J
    Dtsch Med Wochenschr; 1968 Nov; 93(47):2281-2. PubMed ID: 4301079
    [No Abstract]   [Full Text] [Related]  

  • 39. Validation of a rapid method for detection of M. tuberculosis resistance to INH and RMP in Lima, Peru.
    De Kantor IN
    Int J Tuberc Lung Dis; 2006 Jun; 10(6):707; author reply 707-8. PubMed ID: 16776461
    [No Abstract]   [Full Text] [Related]  

  • 40. Post-antibiotic effects of linezolid and other agents against Mycobacterium tuberculosis.
    Hui M; Au-Yeang C; Wong KT; Chan CY; Yew WW; Leung CC
    Int J Antimicrob Agents; 2008 Apr; 31(4):395-6. PubMed ID: 18272351
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.